Publication: Urinary biomarkers for the diagnosis of cervical cancer by quantitative label‑free mass spectrometry analysis
Issued Date
2019-06-01
Resource Type
ISSN
17921082
17921074
17921074
Other identifier(s)
2-s2.0-85065795869
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Oncology Letters. Vol.17, No.6 (2019), 5453-5468
Suggested Citation
Daranee Chokchaichamnankit, Kamolwan Watcharatanyatip, Pantipa Subhasitanont, Churat Weeraphan, Siriporn Keeratichamroen, Narongrit Sritana, Nuttavut Kantathavorn, Penchatr Diskul Na Ayudthaya, Kittirat Saharat, Juthamard Chantaraamporn, Chris Verathamjamras, Natacha Phoolcharoen, Kriangpol Wiriyaukaradecha, Nilubol Monique Paricharttanakul, Wandee Udomchaiprasertkul, Thaniya Sricharunrat, Chirayu Auewarakul, Jisnuson Svasti, Chantragan Srisomsap Urinary biomarkers for the diagnosis of cervical cancer by quantitative label‑free mass spectrometry analysis. Oncology Letters. Vol.17, No.6 (2019), 5453-5468. doi:10.3892/ol.2019.10227 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/50168
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Urinary biomarkers for the diagnosis of cervical cancer by quantitative label‑free mass spectrometry analysis
Author(s)
Daranee Chokchaichamnankit
Kamolwan Watcharatanyatip
Pantipa Subhasitanont
Churat Weeraphan
Siriporn Keeratichamroen
Narongrit Sritana
Nuttavut Kantathavorn
Penchatr Diskul Na Ayudthaya
Kittirat Saharat
Juthamard Chantaraamporn
Chris Verathamjamras
Natacha Phoolcharoen
Kriangpol Wiriyaukaradecha
Nilubol Monique Paricharttanakul
Wandee Udomchaiprasertkul
Thaniya Sricharunrat
Chirayu Auewarakul
Jisnuson Svasti
Chantragan Srisomsap
Kamolwan Watcharatanyatip
Pantipa Subhasitanont
Churat Weeraphan
Siriporn Keeratichamroen
Narongrit Sritana
Nuttavut Kantathavorn
Penchatr Diskul Na Ayudthaya
Kittirat Saharat
Juthamard Chantaraamporn
Chris Verathamjamras
Natacha Phoolcharoen
Kriangpol Wiriyaukaradecha
Nilubol Monique Paricharttanakul
Wandee Udomchaiprasertkul
Thaniya Sricharunrat
Chirayu Auewarakul
Jisnuson Svasti
Chantragan Srisomsap
Abstract
© 2019, Spandidos Publications. All rights reserved. Due to the invasive procedure associated with Pap smears for diagnosing cervical cancer and the conservative culture of developing countries, identifying less invasive biomarkers is of great interest. Quantitative label-free mass spectrometry was performed to identify potential biomarkers in the urine samples of patients with cervical cancer. This technique was used to study the differential expression of urinary proteomes between normal individuals and cancer patients. The alterations in the levels of urinary proteomes in normal and cancer patients were analyzed by Progenesis label-free software and the results revealed that 60 proteins were upregulated while 73 proteins were downregulated in patients with cervical cancer. This method could enrich high molecular weight proteins from 100 kDa. The protein-protein interactions were obtained by Search Tool for the Retrieval of Interacting Genes/Proteins analysis and predicted the biological pathways involving various functions including cell-cell adhesion, blood coagulation, metabolic processes, stress response and the regulation of morphogenesis. Two notable upregulated urinary proteins were leucine-rich α-2-glycoprotein (LRG1) and isoform-1 of multimerin-1 (MMRN1), while the 3 notable downregulated proteins were S100 calcium-binding protein A8 (S100A8), serpin B3 (SERPINB3) and cluster of differentiation-44 antigen (CD44). The validation of these 5 proteins was performed by western blot analysis and the biomarker sensitivity of these proteins was analyzed individually and in combination with receiver operator characteristic curve (ROC) analysis. Quantitative mass spectrometry analysis may allow for the identification of urinary proteins of high molecular weight. The proteins MMRN1 and LRG1 were presented, for the first time, to be highly expressed urinary proteins in cervical cancer. ROC analysis revealed that LRG1 and SERPINB3 could be individually used, and these 5 proteins could also be combined, to detect the occurrence of cervical cancer.